Cargando…
Conversion of Tuberculosis Screening Tests During Biologic Therapy Among Veteran Patient Population With Rheumatic Disease
OBJECTIVE: The optimal strategy to detect the development of tuberculosis (TB) in subjects receiving biologic agents is not clear. The recommendations vary because there is wide variation in the reported rate of seroconversion in various parts of the world. There is a scarcity of long‐term studies r...
Autores principales: | Pattanaik, Debendra, Gupta, Sandeep, Islam, Syed, Singhal, Kunal, Raza, Syed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857984/ https://www.ncbi.nlm.nih.gov/pubmed/31777837 http://dx.doi.org/10.1002/acr2.11070 |
Ejemplares similares
-
Systemic Lupus Erythematosus (SLE) and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis (AAV) Overlap Syndrome: Case Report and Review of the Literature
por: Itikyala, Sathish, et al.
Publicado: (2019) -
Adherence and systemic reaction rates to allergy immunotherapy among veterans
por: Ellenburg, Joseph T., et al.
Publicado: (2016) -
Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic Treatment
por: Thomas, Konstantinos, et al.
Publicado: (2020) -
Tuberculosis in Children with Rheumatic Diseases Treated with Biologic Disease-Modifying Anti-Rheumatic Drugs
por: Kavadichanda, Chengappa, et al.
Publicado: (2021) -
Pregnancy Intention Screening in Patients With Systemic Rheumatic Diseases: Pilot Testing a Standardized Assessment Tool
por: Pryor, Katherine P., et al.
Publicado: (2022)